UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
 
SCHEDULE 13G*
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2
(Amendment No. ___)*
 
 
Corbus Pharmaceuticals Holdings, Inc.
(Name of Issuer)
 
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
 
 

21833P103

(CUSIP Number)
 
 

December 31, 2014

(Date of Event Which Requires Filing of the Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

¨Rule 13d-1(b)

 

xRule 13d-1(c)

 

¨Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

 

 Page 1 of 7 
 

Cusip No.  21833P103 13G Page 2 of 7 Pages

 

 

 

1.

 

NAME OF REPORTING PERSONS

 

Knoll Capital Management, LP

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)      ¨

(b)     x

 

 

3.

 

SEC USE ONLY

 

   
4.


CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

 

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

 

5.

 

SOLE VOTING POWER

 

0

 

6.

 

SHARED VOTING POWER

 

2,750,000

 

7.

 

SOLE DISPOSITIVE POWER

 

0

 

8.

 

 

SHARED DISPOSITIVE POWER

 

2,750,000

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,750,000

 

10.

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

¨

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

8.5%

 

12.

 

 

TYPE OF REPORTING PERSON

 

PN

       

 

 Page 2 of 7 
 

Cusip No.  21833P103 13G Page 3 of 7 Pages

 

 

 

1.

 

NAME OF REPORTING PERSONS

 

Fred Knoll

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)      ¨

(b)     x

 

 

3.

 

SEC USE ONLY

 

 

4.

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

 

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

 

5.

 

SOLE VOTING POWER

 

0

 

6.

 

SHARED VOTING POWER

 

2,750,000

 

7.

 

SOLE DISPOSITIVE POWER

 

0

 

8.

 

 

SHARED DISPOSITIVE POWER

 

2,750,000

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,750,000

 

10.

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

¨

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

8.5%

 

12.

 

 

TYPE OF REPORTING PERSON

 

IN

       

 

 Page 3 of 7 
 

Cusip No.  21833P103 13G Page 4 of 7 Pages

 

 

 

1.

 

NAME OF REPORTING PERSONS

 

Europa International, Inc.

 

2.

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(see instructions)

(a)      ¨

(b)     x

 

 

3.

 

SEC USE ONLY

 

 

4.

 

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

British Virgin Islands

 

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

 

5.

 

SOLE VOTING POWER

 

0

 

6.

 

SHARED VOTING POWER

 

2,750,000

 

7.

 

SOLE DISPOSITIVE POWER

 

0

 

8.

 

 

SHARED DISPOSITIVE POWER

 

2,750,000

 

9.

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,750,000

 

10.

 

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

¨

 

11.

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

8.5%

 

12.

 

 

TYPE OF REPORTING PERSON

 

CO

       

 

 Page 4 of 7 
 

Cusip No.  21833P103 13G Page 5 of 7 Pages

 

 

Item 1(a).Name of Issuer:

 

Corbus Pharmaceuticals Holdings, Inc. (the “Issuer”)

 

Item 1(b).Address of Issuer’s Principal Executive Offices:

 

100 River Ridge Drive

Norwood, Massachusetts 02062

 

Item 2(a).Name of Persons Filing:

 

Knoll Capital Management LP (“KCMLP”)

Fred Knoll (“Knoll”)

Europa International, Inc. (“Europa”)

Item 2(b).Address of Principal Business Office or, if none, Residence:

 

The principle business address for each of KCMLP, Knoll and Europa is 5 East 44th Street, Suite 12, New York, NY 10017


Item 2(c).Citizenship:

 

KCMLP is a limited partnership formed and existing under the laws of the State of Delaware.

Knoll is a citizen of the United States.

Europa is a company organized under the laws of the British Virgin Islands.

 

Item 2(d).Title of Class of Securities:

 

This statement on Schedule 13G is being filed with respect to Common Stock, $0.0001 par value per share (the “Common Stock”) of the issuer.

 

Item 2(e).CUSIP Number:

 

21833P103

 

Item 3.If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: Not applicable

 

  (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C 78o);
       
  (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C 78c);
       
  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C 78c);
       
  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
       
  (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
  (f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
       
  (g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
       
  (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
       
  (j) ¨ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
       
  (k) ¨ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

 

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: _________________

 

 Page 5 of 7 
 

Cusip No.  21833P103 13G Page 6 of 7 Pages

 

 

Item 4.Ownership:

 

Provide the following information regarding the aggregate number and percentage of class of securities of the issuer identified in Item 1.

 

(a)Amount beneficially owned:

 

As of this filing:

 

Europa beneficially owns 2,750,000 Shares of the Issuer’s Common Stock, comprised of 1,750,000 shares of Common Stock and 1,000,000 warrants to purchase the Issuer’s common stock.

 

Each of KCMLP and Knoll beneficially own 2,750,000 Shares of the Issuer’s Common Stock, comprised of 1,750,000 shares on Common Stock and 1,000,000 warrants to purchase the Issuer’s common stock. KCMLP is the investment manager of Europa, and Knoll is the President of KCMLP.

 

(b)Percent of Class:

 

The 2,750,000 shares of the Issuer’s Common Stock beneficially owned by each of Europa, KCMLP and Knoll constitute 8.5% of the Issuer’s Common Stock outstanding.

 

This percentage is calculated based on a total of 31,315,369 shares of the Company’s Common Stock outstanding as of July 24, 2015.

 

(c)Number of shares as to which such person has:

 

(i)sole power to vote or to direct the vote: 0

 

(ii)shared power to vote or to direct the vote: 2,750,000

 

KCMLP, Knoll and Europa share the power to vote or direct the vote of those shares of Common Stock owned by Europa.

 

(iii)sole power to dispose or to direct the disposition of: 0

 

(iv)shared power to dispose or to direct the disposition of: 2,750,000

 

KCMLP, Knoll and Europa share the power to dispose of or direct the disposition of those shares of Common Stock owned by Europa.

 

Item 5.Ownership of Five Percent or Less of a Class:

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ¨.

 

Item 6.Ownership of More than Five Percent on Behalf of Another Person:

  

Not Applicable.

 

Item 7.Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:

 

Not Applicable.

 

Item 8.Identification and Classification of Members of the Group:

 

Not Applicable.

 

Item 9.Notice of Dissolution of Group:

 

Not Applicable

 

Item 10.Certifications:

 

By Signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

 Page 6 of 7 
 

Cusip No.  21833P103 13G Page 7 of 7 Pages

 

 

SIGNATURE

 

After reasonable inquiry and to the best of its knowledge and belief, I certify (the undersigned certifies) that the information set forth in this statement is true, complete and correct.

 

 

 

KNOLL CAPITAL MANAGEMENT, LP

 

 

By: /s/ Fred Knoll

Dated: August 04, 2015

Name: Fred Knoll

Title: President

 

 

 

 

/s/ Fred Knoll

Dated: August 04, 2015 Fred Knoll
 

 

EUROPA INTERNATIONAL, INC
By: Knoll Capital Management, L.P.,

Investment Manager

 

 

 

By: /s/ Fred Knoll

Dated: August 04, 2015

Name: Fred Knoll

Title: President

 

 Page 7 of 7